Cost-sharing of 0%, 50% of reference price of subsidised medicines and medical supplies for outpatient treatment, depending on diagnosed diseases, syndromes and conditions specified in the list of diseases and subsidised medicines to cure them (List A) or in the list of subsidised medical products (List B). the difference between the retail price and “reference price” of subsidised medicines is paid by the patient. certain categories of patients are exempted from paying copayments, the max co-payment rate is defined.